 |
|
Management of Disorders of Cholesterol, Triglyceride, and Lipoprotein MetabolismReport 6 of the Council on Scientific Affairs
Council on Scientific Affairs
Arch Fam Med. 1995;4(10):869-878.
References
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
| |
1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA. 1993;269:3015-3023.
2. American Heart Association. 1993 Heart and Stroke Facts Statistics. Dallas, Tex: American Heart Association; 1992. 3. Clarkson TB, Prichard RW, Morgan TM, Petrick GS, Klein KP. Remodeling of coronary arteries in human and nonhuman primates. JAMA. 1994;271:289-294.
FREE FULL TEXT
4. Shipley MJ, Pocock SJ, Marmot MG. Does plasma cholesterol concentration predict mortality from coronary heart disease in elderly people? 18 year follow up in Whitehall study. BMJ. 1991;303:89-92.
FREE FULL TEXT
5. Castelli WP, Anderson K, Wilson PWF, Levy D. Lipids and risk of coronary heart disease: the Framingham Study. Ann Epidemiol. 1992;2:23-28.
PUBMED
6. Manolio TA, Pearson TA, Wenger NK, Barrett-Connor E, Payne GH, Harlan WR. Cholesterol and heart disease in older persons and women: review of an NHLBI workshop. Ann Epidemiol. 1992;2:161-176.
PUBMED
7. Brown SA, Hutchinson R, Morrisett J, et al. Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities: the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb. 1993;13:1139-1158.
FREE FULL TEXT
8. Farish E, Rolton HA, Barnes JF, Hart DM. Lp[a] concentrations in postmenopausal women taking norethisterone. BMJ. 1991;303:694.
FREE FULL TEXT
9. Soma MR, Fumagalli R, Paoletti R, et al. Plasma Lp(a) concentration after oestrogen and progestagen in postmenopausal women. Lancet. 1991;337:612.
PUBMED
10. National Cholesterol Education Program. Recommendations for Improving Cholesterol Measurement. Bethesda, Md: US Dept of Health and Human Services; 1990. 11. Cashin-Hemphill L. Femoral and coronary angiographic trials. Am J Cardiol. 1993;71:20B 25B.
PUBMED
12. Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results, II: the relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA. 1984;251:365-374.
FREE FULL TEXT
13. Jousilahti P, Vartiainen E, Tuomilehto J, Pekkanen J, Puska P. Effect of risk factors and changes in risk factors on coronary mortality in three cohorts of middle-aged people in eastern Finland. Am J Epidemiol. 1995;141:50-60.
FREE FULL TEXT
14. Manson JE, Tosteson H, Ridker PM, et al. The primary prevention of myocardial infarction. N Engl J Med. 1992;326:1406-1416.
PUBMED
15. Hebert PR, Gaziano JM, Hennekens CH. An overview of trials of cholesterol lowering and risk of stroke. Arch Intern Med. 1995;155:5-55.
16. Denke MA. Cholesterol-lowering diets: a review of the evidence. Arch Intern Med. 1995;155:17-26.
FREE FULL TEXT
17. Denke MA, Grundy SM. Individual responses to a cholesterol-lowering diet in men with moderate hypercholesterolemia. Arch Intern Med. 1994;154:317-325.
FREE FULL TEXT
18. Watts GF, Lewis B, Brunt JNH, et al. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St. Thomas' Atherosclerosis Regression Study (STARS). Lancet. 1992;339:563-569.
PUBMED
19. Datillo AM, Kris-Etherton PM. Effects of weight reduction on blood lipids and lipoproteins: a metaanalysis. Am J Clin Nutr. 1992;56:320-328.
FREE FULL TEXT
20. Gordon DJ, Salz KM, Roggenkamp KJ, Franklin FA Jr. Dietary determinants of plasma cholesterol change in the recruitment phase of the Lipid Research Clinics Primary Prevention Trial. Arteriosclerosis. 1982;2:537-548.
FREE FULL TEXT
21. Leon AS, Connett J, Jacobs DR Jr, Rauramaa R. Leisure-time physical activity levels and risk of coronary heart disease and death: the Multiple Risk Factor Intervention Trial. JAMA. 1987;258:2388-2395.
FREE FULL TEXT
22. Powell KE, Thompson PD, Caspersen CJ, Kendrick JS. Physical activity and the incidence of coronary heart disease. Ann Rev Public Health. 1987;8:253-287.
PUBMED
23. Berlin JA, Colditz GA. A meta-analysis of Physical activity in the prevention of coronary heart disease. Am J Epidemiol. 1990;132:612-628.
FREE FULL TEXT
24. Fletcher GF, Blair SN, Blumenthal J, et al. Benefits and recommendations for physical activity programs for all Americans: a statement for health professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology, American Heart Association. Circulation. 1992;86:263-301.
FREE FULL TEXT
25. Schuler G, Hambrecht R, Schlierf G, et al. Regular physical exercise and low-fat diet: effects on progression of coronary artery disease. Circulation. 1992;86:1-11.
FREE FULL TEXT
26. Paffenbarger RS Jr, Hyde RT, Wing AL, Lee I-M, Jung DL, Kampert JB. The association of changes in physical-activity level and other life habits characteristics with mortality among men. N Engl J Med. 1993;328:538-545.
FREE FULL TEXT
27. Rowland TW. Exercise and atherosclerosis in children and adolescents. Cardiovasc Rev Rep. 1985;6:851-857.
28. Epstein LH, Kuller LH, Wing RR, Valoski A, McCurley J. The effect of weight control on lipid changes in obese children. AJDC. 1989;143:545-457.
29. Willett WC, Green A, Stampfer MJ, et al. Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. N Engl J Med. 1987;317:1303-1309.
ABSTRACT
30. LaCroix AZ, Lang J, Scherr P, et al. Smoking and mortality among older men and women in three communities. N Engl J Med. 1991;324:1619-1625.
ABSTRACT
31. Freund KM, Belanger AJ, D'Agostino RB, Kannel WB. The health risks of smoking: the Framingham Study: 34 years of follow-up. Ann Epidemiol. 1993;3:417-424.
PUBMED
32. Witteman JCM, Grobbee DE, Valkenburg HA, van Hemert AM, Stijnen T, Hofman A. Cigarette Smoking and the development and progression of aortic atherosclerosis. Circulation. 1993;88:2156-2162.
FREE FULL TEXT
33. Wolf PA, D'Agostino RB, Kannel WB, Bonita R, Belanger AJ. Cigarette smoking as a risk factor for stroke: the Framingham Study. JAMA. 1988;259:1025-1029.
FREE FULL TEXT
34. Kawachi I, Colditz GA, Stampfer MJ, et al. Smoking cessation and time course of decreased risks of coronary heart disease in middle-aged women. Arch Intern Med. 1994;154:169-175.
FREE FULL TEXT
35. Jooste PL, Rossouw LJ, Steenkamp HJ, Rossouw JE, Swanepoel ASP, Charlton DO. Effect of breast feeding on the plasma cholesterol and growth of infants. J Pediatr Gastroenterol Nutr. 1991;13:139-142.
PUBMED
36. Kallio MJT, Salmenpera L, Siimes MA, Perheentupa J, Miettinen TA. Exclusive breast feeding and weaning: effect on serum cholesterol and lipoprotein concentrations in infants during the first year of life. Pediatrics. 1992;89:663-666.
FREE FULL TEXT
37. Kallio MJT, Salmenpera L, Siimes MA, Perheentupa J, Miettinen TA. Tracking of serum cholesterol and lipoprotein levels from the first year of life. Pediatrics. 1993;91:949-954.
FREE FULL TEXT
38. Hamosh M. Does infant nutrition affect adiposity and cholesterol levels in the adult? J Pediatr Gastroenterol Nutr. 1988;7:10-16.
PUBMED
39. Strong JP, Malcom GT, Newman WP, Oalmann MC. Early lesions of atherosclerosis in childhood and youth: natural history and risk factors. J Am Coll Nutr. 1992;11(suppl):51S-54S.
40. Enos WF, Holmes RH, Beyer J. Coronary disease among United States soldiers killed in action in Korea: preliminary report. JAMA. 1953;152:1090-1093.
FREE FULL TEXT
41. Strong JP, McGill HC Jr. The pediatric aspects of atherosclerosis. J Atheroscler Res. 1969;9:251-265.
PUBMED
42. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Natural history of aortic and coronary atherosclerotic lesions in youth: findings from the PDAY study. Arterioscler Thromb. 1993;13:1291-1298.
FREE FULL TEXT
43. Pathobiological Determinants of Atherosclerosis in Youth Research Group. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking: a preliminary report from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. JAMA. 1990;264:3018-3024.
FREE FULL TEXT
44. Tanganelli P, Bianciardi G, Simoes C, Attino V, Tarabochia B, Weber G. Distribution of lipid and raised lesions in aortas of young people of different geographic origins (WHO-ISFC PBDAY Study). Arterioscler Thromb. 1993;13:1700-1710.
FREE FULL TEXT
45. Berenson GS, Srinivasan SR, Webber LS, et al. Cardiovascular Risk in Early Life: The Bogalusa Heart Study. Kalamazoo, Mich: Upjohn Co; 1991. 46. Benuck I, Gidding SS, Donovan M, Traisman ES, Traisman HS. Usefulness of parental serum total cholesterol levels in identifying children with hypercholesterolemia. Am J Cardiol. 1992;69:713-717.
PUBMED
47. American Academy of Pediatrics Committee on Nutrition. Statement on cholesterol. Pediatrics. 1992;90:469-473.
FREE FULL TEXT
48. International Union of Nutritional Sciences/ World Health Organization. Conclusions, guidelines and recommendations from the IUNS/ WHO Workshop: nutrition in the pediatric age group and later cardiovascular disease. J Am Coll Nutr. 1992;11:1S-2S.
49. National Cholesterol Education Program Expert Panel on Blood Cholesterol Levels in Children and Adolescents. National Cholesterol Education Program: Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Bethesda, Md: National Institutes of Health; 1991. 50. Jiang X, Srinivasan SR, Webber LS, Wattigney WA, Berenson GS. Association of fasting insulin level with serum lipid and lipoprotein levels in children, adolescents, and young adults: the Bogalusa Heart Study. Arch Intern Med. 1995;155:190-196.
FREE FULL TEXT
51. Stuhldreher WL, Orchard TJ, Donahue RP, Kuller LH, Gloninger MF, Drash AL. Cholesterol screening in childhood: sixteen-year Beaver County Lipid Study experience. J Pediatr. 1991;119:551-556.
PUBMED
52. Webber LS, Srinivasan SR, Wattigney WA, Berenson GS. Tracking of serum lipids and lipoproteins from childhood to adulthood: the Bogalusa Heart Study. Am J Epidemiol. 1991;133:884-899.
FREE FULL TEXT
53. Kwiterovich PO Jr. Diagnosis and management of familial dyslipoproteinemia in children and adolescents. Pediatr Clin North Am. 1990;37:1489-1523.
PUBMED
54. Liacouras CA, Coates PM, Gallagher PR, Cortner JA. Use of cholestyramine in the treatment of children with familial combined hyperlipidemia. J Pediatr. 1993;122:477-482.
PUBMED
55. AMA Drug Evaluations. Chicago, Ill: American Medical Association; 1994. 56. Richter WO, Jacob BG, Ritter MM, Schwandt P. Treatment of primary chylomicronemia due to familial hypertriglyceridemia by n-3 fatty acids. Metabolism. 1992;41:1100-1105.
PUBMED
57. Harris WS. Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J Lipid Res. 1989;30:785-807.
ABSTRACT
58. Nestel PJ, Connor WE, Reardon MF, Connor S, Wong S, Boston R. Suppression by diets rich in fish oil of very low density lipoprotein production in man. J Clin Invest. 1984;74:82-89.
PUBMED
59. Phillipson BE, Rothrock BW, Connor WE, Harris WS, Illingworth DR. Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia. N Engl J Med. 1985;312:1210-1216.
ABSTRACT
60. Failor RA, Childs MT, Bierman EL. The effects of omega 3 and omega 6 fatty acid-enriched diets on plasma lipoproteins and apoproteins in familial combined hyperlipidemia. Metabolism. 1988;37:1021-1028.
PUBMED
61. Schectman G, Kaul S, Kissebah AH. Effect of fish oil concentrate on lipoprotein composition in NIDDM. Diabetes. 1988;37:1567-1573.
ABSTRACT
62. Nozaki S, Garg A, Vega GL, Grundy SM. Postheparin lipolytic activity and plasma lipoprotein response to  -3 polyunsaturated fatty acids in patients with primary hypertriglyceridemia. Am J Clin Nutr. 1991;53:638-642.
FREE FULL TEXT
63. Drevon CA. Marine oils and their effects. Nutr Rev. 1992;50:38-45.
PUBMED
64. Malasanos TH, Stacpoole PW. Biological effects of -3 fatty acids in diabetes mellitus. Diabetes Care. 1991;14:1160-1179.
ABSTRACT
65. Mensink RP, Katan MB. Effect of dietary fatty acids on serum lipids and lipoproteins: a metaanalysis of 27 trials. Arterioscler Thromb. 1992;12:911-919.
FREE FULL TEXT
66. Valsta LM, Jauhiainen M, Aro A, Katan MB, Mutanen M. Effects of a monounsaturated repeseed oil and a polyunsaturated sunflower oil diet on lipoprotein levels in humans. Arterioscler Thromb. 1992;12:50-57.
FREE FULL TEXT
67. Grundy SM. Comparison of monounsaturated fatty acids and carbohydrates for lowering plasma cholesterol. N Engl J Med. 1986;314:745-748.
ABSTRACT
68. Kritchevsky D. Evaluation of Publicly Available Scientific Evidence Regarding Certain Nutrient-Disease Relationships, 6: Dietary Fiber and Cardiovascular Disease. Bethesda, Md: Life Sciences Research Office/Federation of American Societies for Experimental Biology; 1991. 69. Harris WS. The prevention of atherosclerosis with antioxidants. Clin Cardiol. 1992;15:636-640.
PUBMED
70. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med. 1993;328:1444-1449.
FREE FULL TEXT
71. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary disease in men. N Engl J Med. 1993;328:1450-1456.
FREE FULL TEXT
72. Yau T, Weisel RD. Mickle DAG, et al. Vitamin E improved myocardial protection. Circulation. 1990;82(suppl_III):III-146. Abstract.
73. DeMaio SJ, King SB, Lembo NJ, et al. Vitamin E supplementation, plasma lipids and incidence of restenosis after percutaneous transluminal coronary angioplasty (PTCA). J Am Coll Nutr. 1992;11:68-73.
ABSTRACT
74. Gaziano JM, Manson JE, Ridker PM, Buring JE, Hennekens CH. Beta carotene therapy for chronic stable angina. Circulation. 1990;82(suppl III):III-201. Abstract.
|
